ROBERT SOLARCZYK: Open Payments
NPI 1982691192 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 10 payments from 5 companies in 2025. Trend: 2023 $717 · 2024 $818 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 6 | $115 |
| MML US, Inc. | 1 | $27 |
| Abbott Laboratories | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Medtronic, Inc. | 1 | $15 |
Products named: XTAMPZA, Belbuca, ReActiv8, PROCLAIM, RELISTOR, INCEPTIV.
Industry payments across MD — which companies pay providers there.
